Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics

Fig. 3

OS curves based on different PLOD2 expression levels. a Kaplan-Meier survival curves for LSCC patients with high PLOD2, CD44 and CD133 expression (red line) versus low PLOD2, CD44 and CD133 expression (blue line). b Kaplan-Meier survival curves for LSCC patients with high PLOD2 and CD44/CD133 expression (red line) versus low PLOD2 and CD44/CD133 expression (blue line)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us